Building Safeguards for Genetically Engineered Microbes
Inside the Lab: How Do Coronavirus Researchers Avoid Catching COVID-19?
Draft Policy Issued for Large Animal Outdoor Containment Select Agent Studies
Validated Methods for Removing Select Agent Samples from BSL-3 Labs
Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module
How is Used PPE Disposed of During the Coronavirus Pandemic?
AFRL Aircraft Decontamination Team Ramps Up Battle Against COVID-19
Washington State Recalls 12,000 COVID-19 Test Kits Due to Possible Contamination
CDC Coronavirus Test Kit Failure Due to Contamination
Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and System
EPA Releases List of Disinfectants to Use Against COVID-19
Whistleblower Complaint Details Chaotic Handling of U.S. Quarantine Logistics, Potential Community Exposures
The Future Biosecurity Implications of Thousands of Samples Taken During Outbreaks
CDC Approves Partial Resumption of USAMRIID Select Agent Research
Biosafety Levels in Laboratories – What is the Difference?
Explosion Confirmed at Russian Lab Storing Smallpox, Ebola
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight
How Does USAMRIID Shut Down Impact Nation’s Bioterrorism Laboratory Response Network?
Congratulations. You've reached the end of the internet.
Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response
Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2
Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks
Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3
ABSA’s 1st Biosecurity Symposium
© 2021 by Stemar Media Group LLC
Back to Top